We further corroborated the prognostic significance of the EIF2S1 gene using a Kaplan–Meier (KM) plotter-based survival analysis of The Cancer Genome Atlas (TCGA)-NB database. This evidence concerns the gene EIF2S1 and neuroblastoma.